Literature DB >> 5000554

Comparative dominant lethal studies with phenylbutazone, thio-TEPA and MMS in the mouse.

L Machemer, R Hess.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5000554     DOI: 10.1007/bf02138874

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


× No keyword cloud information.
  4 in total

1.  [Study on the reproducibility of the dominant lethal test in the mouse using cyclophosphamide and triaziquone].

Authors:  L Machemer; E G Stenger
Journal:  Arzneimittelforschung       Date:  1971-07

2.  Chemical mutagens in the human environment.

Authors:  S S Epstein; H Shafner
Journal:  Nature       Date:  1968-07-27       Impact factor: 49.962

3.  Induction of dominant lethal mutations by alkylating agents in male mice.

Authors:  U H Ehling; R B Cumming; H V Malling
Journal:  Mutat Res       Date:  1968 May-Jun       Impact factor: 2.433

4.  Mutagenicity tests in mice. I. The dominant lethal method and the control problem.

Authors:  G Röhrborn
Journal:  Humangenetik       Date:  1968
  4 in total
  5 in total

1.  Embryolethality in the mouse following treatment of males with cyclophosphamide at specific germ cell stages.

Authors:  H Fritz; D Müller; R Hess
Journal:  Agents Actions       Date:  1973-05

2.  Dominant lethal test in the mouse for mutagenic effects of saccharine.

Authors:  L Machemer; D Lorke
Journal:  Humangenetik       Date:  1973-07-20

3.  Induced dominant lethals in female mice: effects of triaziquone and phenylbutazone.

Authors:  L Machemer; R Hess
Journal:  Experientia       Date:  1973-02-15

4.  Comparative cytogenetic studies of the influence of phenylbutazone and cyclophosphamide on spermatogenesis in the mouse.

Authors:  R Rathenberg; D Müller
Journal:  Agents Actions       Date:  1972-06

5.  Thiono compounds. 4. In vitro mutagenic and antineoplastic activity of TEPA and thio-TEPA.

Authors:  A P Breau; L Field; W M Mitchell
Journal:  Cell Biol Toxicol       Date:  1984-10       Impact factor: 6.691

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.